A new study shows lipid nanoparticles can be formulated at much higher lipid concentrations using a modular mixing approach, ...

With a shared purpose, we can realize the true promise of CRISPR and improve healthcare, providing hope to more patients with ...

Sustained interest in small molecules, bispecific antibodies, and genomics got the ball rolling in the biotech deals arena in ...

UpGuard, a leader in cybersecurity and risk management, released new research highlighting a critical security vulnerability within developer workflows. UpGuard's analysis of more than 18,000 AI agent ...

Aro Biotherapeutics, a clinical-stage biotechnology company developing potent and tissue-targeted short-interfering RNA (siRNA) medicines, today announced interim data from a phase 1b study of ABX1100 ...

Sanofi announced the signing of a share buyback mandate for up to €1 billion. Pfizer said its obesity injection, which was ...

Dario Amodei, CEO of Anthropic, says more democracy is the best response to AI. He doesn’t sound too confident.

The Seattle facility of AGC Biologics, your friendly CDMO expert, has received a Good Manufacturing Practices Certification from Agência Nacional de Vigilância Sanitária (Anvisa), Brazil's health ...

Learn which nanocarriers matter now (LNPs, exosomes, polymers) and the key hurdles in biodistribution, safety, CMC, and ...

According to the agreement, Everest Medicines will pay Micot an upfront payment of RMB 200 million and potential regulatory and commercial milestone payments of up to RMB 1,040 million. MT1013 has ...

Luke Miels' first financial results since taking over as chief executive of GSK revealed a jump in sales and profits, fuelled ...

The loss of market exclusivity for a trio of big-selling drugs in the last quarter of 2025 dragged down Novartis sales, but ...